Research theme for competitive and other funds (1):
2021 - 2024 Development of minimally invasive therapy focusing on the molecular mechanism of hypoxia in human papilloma virus-related head and neck cancer
Hirakawa H, Ikegami T, Touyama M, Ooshiro Y, Higa T, Higa T, Agena S, Kinjyo H, Kondo S, Kise N, et al. p16 Overexpression in Sinonasal Squamous Cell Carcinoma: Association with Human Papillomavirus and Prediction of Survival Outcomes. Journal of Clinical Medicine. 2023. 12. 21. 6861
Tanaka, K, Hirakawa, H, Suzuki, M, Higa, T, Agena, S, Hasegawa, N, Kawakami, J, Toyama, M, Higa, T, Kinjyo, H, et al. Programmed Cell Death-1 Antibody Treatment Effects in Head and Neck Cancer. Current Oncology. 2023. 2023,. 30. 5409-5424